415 related articles for article (PubMed ID: 25563231)
1. Clinicopathological and outcome analysis of adult lupus nephritis patients in China.
Tang Y; Zhang X; Ji L; Mi X; Liu F; Yang L; Qin W
Int Urol Nephrol; 2015 Mar; 47(3):513-20. PubMed ID: 25563231
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
[TBL] [Abstract][Full Text] [Related]
3. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
4. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.
Li C; Zhou ML; Liang DD; Wang JJ; Yang J; Zeng CH; Liu ZH; Zhang HT
BMJ Open; 2017 Jul; 7(7):e015668. PubMed ID: 28756384
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
7. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of clinical presentation of lupus nephritis.
Singh S; Zhou XJ; Ahn C; Saxena R
Am J Med Sci; 2011 Dec; 342(6):467-73. PubMed ID: 21681076
[TBL] [Abstract][Full Text] [Related]
9. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.
Al Arfaj AS; Khalil N; Al Saleh S
Rheumatol Int; 2009 Jul; 29(9):1057-67. PubMed ID: 19381639
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
[TBL] [Abstract][Full Text] [Related]
11. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies.
Jin SY; Huang DL; Dang XQ; Yi ZW
Paediatr Int Child Health; 2017 Nov; 37(4):286-291. PubMed ID: 28463080
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka.
Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N
BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285
[TBL] [Abstract][Full Text] [Related]
13. The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis.
Koo HS; Kim YC; Lee SW; Kim DK; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Chin HJ
Lupus; 2011 Nov; 20(13):1442-9. PubMed ID: 21951944
[TBL] [Abstract][Full Text] [Related]
14. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
Mitwalli AH; Hayat A; Alwakeel J; Hammad D
Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
16. Presentation and Treatment Outcomes of 100 Lupus Nephritis Patients: Single Center Study.
Faroque MO; Hadiuzzaman KM; Islam SF; Hossain RM; Islam MN; Ahmed AH; Ahmed PI; Alam MR
Mymensingh Med J; 2016 Apr; 25(2):308-15. PubMed ID: 27277365
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
[TBL] [Abstract][Full Text] [Related]
18. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
19. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
Zhang J; Lian R; Chen Y; Wan J
Ren Fail; 2024 Dec; 46(2):2357743. PubMed ID: 38847502
[TBL] [Abstract][Full Text] [Related]
20. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
